T3379
DL-酪氨酸
≥98% (TLC)
别名:
(±)-2-氨基-3-(4-羟基苯基)丙酸, 3-(4-羟基苯基)-DL-丙氨酸
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
4-(HO)C6H4CH2CH(NH2)COOH
化学文摘社编号:
分子量:
181.19
EC Number:
209-113-1
UNSPSC Code:
12352200
MDL number:
Beilstein/REAXYS Number:
515881
InChI
1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)
InChI key
OUYCCCASQSFEME-UHFFFAOYSA-N
SMILES string
NC(Cc1ccc(O)cc1)C(O)=O
assay
≥98% (TLC)
mp
≥300 °C (lit.)
正在寻找类似产品? 访问 产品对比指南
Biochem/physiol Actions
多巴胺和其他儿茶酚胺的氨基酸前体
法规信息
新产品
此项目有
Shannon L Maude et al.
Blood, 125(11), 1759-1767 (2015-02-04)
Early T-cell precursor (ETP) acute lymphoblastic leukemia (ALL) is a recently described subtype of T-ALL characterized by a unique immunophenotype and genomic profile, as well as a high rate of induction failure. Frequent mutations in cytokine receptor and Janus kinase
W D Phillips et al.
Experimental neurology, 270, 29-40 (2014-12-30)
Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several
Philippe Menasché et al.
European heart journal, 36(12), 743-750 (2014-05-20)
There is now compelling evidence that cells committed to a cardiac lineage are most effective for improving the function of infarcted hearts. This has been confirmed by our pre-clinical studies entailing transplantation of human embryonic stem cell (hESC)-derived cardiac progenitors
S P Gorantla et al.
Leukemia, 29(8), 1763-1770 (2015-03-13)
FIP1L1-PDGFRA is a constitutively activated kinase described in chronic eosinophilic leukemia (CEL) and hypereosinophilic syndrome (HES). Imatinib is clinically active in FIP1L1-PDGFRA-positive diseases. Using in vitro screening to identify imatinib-resistant mutations, we frequently detected a Phe to Ser exchange at
Martin Schlumberger et al.
The New England journal of medicine, 372(7), 621-630 (2015-02-12)
Lenvatinib, an oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, fibroblast growth factor receptors 1 through 4, platelet-derived growth factor receptor α, RET, and KIT, showed clinical activity in a phase 2 study involving patients with
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持